Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, recommends how to reduce the risk of Lyme disease.
Zoonotic & Vector-Borne Diseases
Latest News
Advertisement
Advertisement
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains what the CDC is doing about Zika.
A new Zika virus case cluster has emerged in Miami, according to the Florida Department of Health.
Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses whether the new Lyme-carrying bacteria, Borrelia mayonii, has different effects than Borrelia burgdorferi.
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains how the Zika outbreak in Florida shed light on methods to control the spread of the virus.
Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses how symptoms associated with Lyme arthritis differ from those of rheumatoid arthritis.
A recent study details a case of a man with a confirmed Zika virus infection accompanied by papular descending eruption, petechiae on his palate, and hyperemic sclerae.
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains what is currently known about Zika and Dengue coinfection.
Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, explains how clinicians should manage patients with so-called “chronic Lyme disease.”
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses whether or not there are differences between US-acquired Zika and non-US acquired Zika virus cases.
Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses tests used to diagnose Lyme disease and the potential consequences of misdiagnosis.
Researchers have now identified virologic evidence of Zika virus in patients with Guillain-Barré syndrome, showing that the onset of the neurologic disorder can parallel the onset of systemic manifestations of the mosquito-borne infection.
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), gives a brief overview of Zika Virus.
Thanks to the recently approved $1.1 billion in federal funding to support Zika virus-related efforts, various government agencies are ramping up efforts to develop novel vaccines designed to prevent infection.
Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, provides a brief overview of Lyme disease.
The Centers for Disease Control and Prevention (CDC) has updated its interim guidance for “pre-pregnancy counseling” for Zika virus, just as new information regarding sexual transmission of the infection has been made available.
Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), explains how the Zika virus spread to the United States.
Richard Krieger, MD, chairman of the Infection Control Committee at Chilton Medical Center, and infectious disease physician at ID care, discusses how clinicians go about diagnosing Lyme disease.
Just when residents in the Miami area thought the need to fear mosquito-borne viruses was over, Florida health officials revealed that they have identified a locally-transmitted case of Dengue virus.
Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the prognosis of babies with Zika-related complications.
Researchers at Stanford University School of Medicine have potentially added to existing knowledge with regard to how Zika virus affects the developing fetal brain.
Congressional leaders brokered a compromise Wednesday that keeps the government running, provides financial relief to the beleaguered city of Flint, Michigan, and finally funds Zika prevention efforts.
Babies born to mothers infected with the Zika during pregnancy may have the virus in their systems for more than 2 months after birth.
Despite the ongoing funding stalemate in Congress, several research initiatives hoping to yield an effective vaccine against Zika are advancing through the development process.
Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses whether or not all Zika-infected pregnant women will infect their fetuses.
Advertisement
Advertisement